Merck & Co buys UK contract manufacturer Avecia Biologics
This article was originally published in Scrip
Executive Summary
Merck & Co is to acquire Avecia Biologics, a biological contract manufacturer based in Billingham, UK. Merck had already entered into a strategic development and supply relationship with the firm, and said that the acquisition would provide it with an operational facility and experienced workforce skilled in a range of bioprocess systems.